To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Summary
What This Bill Does
The bill provides findings; sense of the Senate Congress finds the following: Direct-to-consumer advertising of prescription pharmaceuticals is legally permitted in only 2 developed countries, the United States and New Zealand, provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Part A of title XI of the Social Security Act is amended by adding at, and provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Subject to paragraph (2), the Secretary shall require that each. It relies on definition changes, appropriations, reporting requirements, and compliance mandates. The main policy areas are Healthcare Consumers, Housing, Healthcare, and Environment.
Who Benefits and How
Patients and health care consumers affected by the bill could face lower compliance burdens, Homeowners, tenants, or housing market participants affected by the bill could face lower compliance burdens, and Foreign businesses and cross-border trade participants affected by the bill could face lower compliance burdens.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Lobbyists, political organizations, and disclosure users affected by the bill would take on compliance duties.
Key Provisions
- Provides findings; sense of the Senate Congress finds the following: Direct-to-consumer advertising of prescription pharmaceuticals is legally permitted in only 2 developed countries, the United States and New Zealand.
- Provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Part A of title XI of the Social Security Act is amended by adding at...
- Provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Subject to paragraph (2), the Secretary shall require that each...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill provides findings; sense of the Senate Congress finds the following: Direct-to-consumer advertising of prescription pharmaceuticals is legally permitted in only 2 developed countries, the United States and New Zealand, provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Part A of title XI of the Social Security Act is amended by adding at, and provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Subject to paragraph (2), the Secretary shall require that each.
Key Policy Areas
Healthcare Consumers, Housing, Healthcare, Environment
Primary Purpose
The bill provides findings; sense of the Senate Congress finds the following: Direct-to-consumer advertising of prescription pharmaceuticals is legally permitted in only 2 developed countries, the United States and New Zealand, provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Part A of title XI of the Social Security Act is amended by adding at, and provides requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Subject to paragraph (2), the Secretary shall require that each.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Foreign businesses and cross-border trade participants affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Lobbyists, political organizations, and disclosure users affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Environmental and public health interests affected by the bill
Sponsors
Legislative Progress
IntroducedMr. Durbin (for himself, Mr. Grassley, Mr. King, Mr. Braun, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology